Condition: Nephrotic Syndrome · Sponsor: Mario Negri Institute for Pharmacological Research
This retrospective study is aimed at evaluating the levels of circulating anti-nephrin autoantibodies in patients with INS, including those with MCD/FSGS and in patients who have experienced relapse of FSGS post-transplant, compared to those of a control group of patients with nephrotic syndrome due to primary membranous nephropathy (MN).
This description comes directly from the study's public registry record.
Federica Casiraghi, PhD · +3903545351 · federica.casiraghi@marionegri.it
Norberto Perico, MD · +3903545351 · norberto.perico@marionegri.it
Always discuss trial participation with your own doctor first.
| Clinical Research Center for Rare Disease Aldo e Cele Daccò | Ranica, BG, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06334692